- 中文名稱
2,3-dinor Prostaglandin E1 (1 mg)
- 英文名字
- 2,3-dinor PGE1, 2,3-dinor Prostaglandin E1, 9-oxo-11.alpha.,15S-dihydroxy-2,3-dinor-prost-13E-en-1-oic acid
- 供應商
- Cayman
- 產品貨號
- 13120-1
- 產品報價
- ¥16856/1 mg

- 產品說明書
- 點擊查看
- 購買方式
- 產品新聞
- 背景資料
- Prostaglandin E1 -PGE1) is not a major naturally occurring prostaglandin, but it is widely administered clinically for several indications including peripheral occlusive vascular disease, erectile dysfunction and in neonatal cardiology. The metabolism of PGE1 is normally initiated by oxidation at C-15, resulting in 13,14-dihydro-15-keto PGE1 as the major metabolite. However, inhibition of this pathway or saturation by excess substrate could theoretically lead to enhanced production of 2,3-dinor metabolites, including 2,3-dinor PGE1. The biological activity of 2,3-dinor PGE1 has not been published. Cayman Chemical is a leading supplier of prostaglandins and their metabolites, and is currently the exclusive manufacturer of 2,3-dinor PGE1.
- 產品描述
- PGE1 is not a major naturally occurring prostaglandin, but it is widely administered clinically for several indications including peripheral occlusive vascular disease, erectile dysfunction, and in neonatal cardiology.{22,3803} The metabolism of PGE1 is normally initiated by oxidation at C-15, resulting in 13,14-dihydro-15-keto PGE1 as the major metabolite. However, inhibition of this pathway or saturation by excess substrate could theoretically lead to enhanced production of 2,3-dinor metabolites, including 2,3-dinor PGE1. The biological activity of 2,3-dinor PGE1 has not been published.
- 產品形式
- 保存建議
- -20
- 其他
- Cayman Chemical

- 注意
-
該頁面的中文產品信息的翻譯,僅供參考。準確的產品信息請以廠家的英文說明書為準。下單前,請瀏覽說明書確認。
-